Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
3,610
Views
43
CrossRef citations to date
0
Altmetric
Coronaviruses

Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2

Bingjie Hua State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Jasper Fuk-Woo Chana State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Infectious Disease and Microbiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of China;c Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Sha Tin, Hong Kong Special Administrative Region, People’s Republic of China;d Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;e Academician Workstation of Hainan Province, Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, Hainan Medical University, Haikou, People’s Republic of China;f Guangzhou Laboratory, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-6336-6657View further author information
ORCID Icon,
Huan Liua State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Yuanchen Liua State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Yue Chaia State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Jialu Shia State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Huiping Shuaia State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Yuxin Houa State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Xiner Huanga State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-0154-8372View further author information
ORCID Icon,
Terrence Tsz-Tai Yuena State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Chaemin Yoona State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Tianrenzheng Zhua State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Jinjin Zhanga State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Wenjun Lig CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People’s Republic of ChinaView further author information
,
Anna Jinxia Zhanga State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;c Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Sha Tin, Hong Kong Special Administrative Region, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-5087-3614View further author information
ORCID Icon,
Jie Zhoua State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;c Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Sha Tin, Hong Kong Special Administrative Region, People’s Republic of ChinaView further author information
,
Shuofeng Yuana State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Infectious Disease and Microbiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of China;c Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Sha Tin, Hong Kong Special Administrative Region, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7996-1119View further author information
ORCID Icon,
Bao-Zhong Zhangg CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People’s Republic of ChinaView further author information
,
Kwok-Yung Yuena State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Infectious Disease and Microbiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of China;c Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Sha Tin, Hong Kong Special Administrative Region, People’s Republic of China;d Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;e Academician Workstation of Hainan Province, Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, Hainan Medical University, Haikou, People’s Republic of China;f Guangzhou Laboratory, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2083-1552View further author information
ORCID Icon &
Hin Chua State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Infectious Disease and Microbiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of China;c Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Sha Tin, Hong Kong Special Administrative Region, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2855-9837View further author information
ORCID Icon show all
Pages 2275-2287 | Received 24 Jun 2022, Accepted 21 Aug 2022, Published online: 28 Sep 2022

Citations (43)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shuai Xia, Lijue Wang, Fanke Jiao, Xueying Yu, Wei Xu, Ziqi Huang, Xicheng Li, Qian Wang, Yun Zhu, Qiuhong Man, Shibo Jiang & Lu Lu. (2023) SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors. Emerging Microbes & Infections 12:1.
Read now
Denilson Ferreira de Oliveira. In silico identification of five binding sites on the SARS-CoV-2 spike protein and selection of seven ligands for such sites. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now

Articles from other publishers (41)

Micheli Filippi, Meriane Demoliner, Juliana Schons Gularte, Vyctoria Malayhka de Abreu Goes Pereira, Mariana Soares da Silva, Viviane Girardi, Alana Witt Hansen & Fernando Rosado Spilki. (2024) Relative frequency of genomic mutations in SARS-CoV-2 recovered from southern Brazilian cases of COVID-19 through the Gamma, Delta and Omicron waves. Infection, Genetics and Evolution 120, pages 105590.
Crossref
Jimena Pérez-Vargas, Gabriel Lemieux, Connor A.H. Thompson, Antoine Désilets, Siobhan Ennis, Guang Gao, Danielle G. Gordon, Annika Lea Schulz, Masahiro Niikura, Ivan Robert Nabi, Mel Krajden, Pierre-Luc Boudreault, Richard Leduc & François Jean. (2024) Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals. Antiviral Research 225, pages 105869.
Crossref
Vladimir Staroverov, Alexei Galatenko, Evgeny Knyazev & Alexander Tonevitsky. (2024) Mathematical model explains differences in Omicron and Delta SARS-CoV-2 dynamics in Caco-2 and Calu-3 cells. PeerJ 12, pages e16964.
Crossref
Annelise Bocquet-Garçon. (2024) Impacts of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review. Cureus.
Crossref
Mathias Martins, Mohammed Nooruzzaman, Jessie Lee Cunningham, Chengjin Ye, Leonardo Cardia Caserta, Nathaniel Jackson, Luis Martinez-Sobrido, Ying Fang & Diego G. Diel. (2024) The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection. Journal of Virology 98:3.
Crossref
Rong-Meng Jiang, Zheng-De Xie, Yi Jiang, Xiao-Xia Lu, Run-Ming Jin, Yue-Jie Zheng, Yun-Xiao Shang, Bao-Ping Xu, Zhi-Sheng Liu, Gen Lu, Ji-Kui Deng, Guang-Hua Liu, Xiao-Chuan Wang, Jian-She Wang, Lu-Zhao Feng, Wei Liu, Yi Zheng, Sai-Nan Shu, Min Lu, Wan-Jun Luo, Miao Liu, Yu-Xia Cui, Le-Ping Ye, A-Dong Shen, Gang Liu, Li-Wei Gao, Li-Juan Xiong, Yan Bai, Li-Kai Lin, Zhuang Wei, Feng-Xia Xue, Tian-You Wang, Dong-Chi Zhao, Jian-Bo Shao, Daniel Kwok-keung Ng, Gary Wing-kin Wong, Zheng-Yan Zhao, Xing-Wang Li, Yong-Hong Yang & Kun-Ling Shen. (2023) Diagnosis, treatment and prevention of severe acute respiratory syndrome coronavirus 2 infection in children: experts’ consensus statement updated for the Omicron variant. World Journal of Pediatrics 20:3, pages 272-286.
Crossref
Ahmed Bouna, Ahmed Atef, Hadiah Bassam Al-Mahdi, Ola H. Elgaddar, Mai M. Labib, Sherif Edris, Alawiah M. Alhebshi, Nahid H. Hajarah, Ahmed Bahieldin, Irfan A. Rather & Jamal S.M. Sabir. (2024) Next generation sequencing shows diversity of Omicron sub-lineages of SARS-COV2 circulating in Jeddah, Saudi Arabia. Journal of King Saud University - Science 36:2, pages 103081.
Crossref
Fabian Zech, Christoph Jung, Timo Jacob & Frank Kirchhoff. (2024) Causes and Consequences of Coronavirus Spike Protein Variability. Viruses 16:2, pages 177.
Crossref
Bingjie Hu, Jasper Fuk-Woo Chan, Yuanchen Liu, Huan Liu, Yan-Xia Chen, Huiping Shuai, Ye-Fan Hu, Madeline Hartnoll, Li Chen, Yao Xia, Jing-Chu Hu, Terrence Tsz-Tai Yuen, Chaemin Yoon, Yuxin Hou, Xiner Huang, Yue Chai, Tianrenzheng Zhu, Jialu Shi, Yang Wang, Yixin He, Jian-Piao Cai, Jie Zhou, Shuofeng Yuan, Jinxia Zhang, Jian-Dong Huang, Kwok-Yung Yuen, Kelvin Kai-Wang To, Bao-Zhong Zhang & Hin Chu. (2024) Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract. eBioMedicine 99, pages 104916.
Crossref
Ruth J. Parsons & Priyamvada Acharya. (2023) Evolution of the SARS-CoV-2 Omicron spike. Cell Reports 42:12, pages 113444.
Crossref
Anacleto Silva de Souza, Robson Francisco de Souza & Cristiane Rodrigues Guzzo. (2023) Cooperative and structural relationships of the trimeric Spike with infectivity and antibody escape of the strains Delta (B.1.617.2) and Omicron (BA.2, BA.5, and BQ.1). Journal of Computer-Aided Molecular Design 37:12, pages 585-606.
Crossref
Dongbum Kim, Jinsoo Kim, Minyoung Kim, Heedo Park, Sangkyu Park, Sony Maharjan, Kyeongbin Baek, Bo Min Kang, Suyeon Kim, Man-Seong Park, Younghee Lee & Hyung-Joo Kwon. (2023) Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Chiara Pastorio, Sabrina Noettger, Rayhane Nchioua, Fabian Zech, Konstantin M.J. Sparrer & Frank Kirchhoff. (2023) Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization. iScience 26:11, pages 108299.
Crossref
Gerald H. Lushington, Annika Linde & Tonatiuh Melgarejo. (2023) Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog. BioTech 12:4, pages 61.
Crossref
Romano Strobelt, Julia Adler & Yosef Shaul. (2023) The Transmembrane Protease Serine 2 (TMPRSS2) Non-Protease Domains Regulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike-Mediated Virus Entry. Viruses 15:10, pages 2124.
Crossref
Masaharu Shin-Ya, Maiko Nakashio, Eriko Ohgitani, Akiko Suganami, Masaya Kawamoto, Masaki Ichitani, Makoto Kobayashi, Takanobu Takihara, Tohru Inaba, Yoko Nukui, Hitoshi Kinugasa, Hiroyasu Ishikura, Yutaka Tamura & Osam Mazda. (2023) Effects of tea, catechins and catechin derivatives on Omicron subvariants of SARS-CoV-2. Scientific Reports 13:1.
Crossref
Yoshikazu Honda‐Okubo, Anna Antipov, Greiciely Andre, Saghar Barati, Hamidreza Kafi & Nikolai Petrovsky. (2023) Ability of SpikoGen ®, an Advax‐CpG adjuvanted recombinant spike protein vaccine, to induce cross‐neutralising antibodies against SARS‐CoV ‐2 variants . Immunology 170:2, pages 193-201.
Crossref
Robério Amorim de Almeida Pondé. (2023) Physicochemical effects of emerging exchanges on the spike protein's RBM of the SARS-CoV-2 Omicron subvariants BA.1-BA.5 and its influence on the biological properties and attributes developed by these subvariants. Virology 587, pages 109850.
Crossref
Anna Z Mykytyn, Ron AM Fouchier & Bart L Haagmans. (2023) Antigenic evolution of SARS coronavirus 2. Current Opinion in Virology 62, pages 101349.
Crossref
Chian Ho, Wan Fahmi Wan Mohamad Nazarie & Ping-Chin Lee. (2023) An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein. Viruses 15:9, pages 1930.
Crossref
Huiping Shuai, Jasper Fuk-Woo Chan, Bingjie Hu, Yue Chai, Chaemin Yoon, Huan Liu, Yuanchen Liu, Jialu Shi, Tianrenzheng Zhu, Jing-Chu Hu, Ye-fan Hu, Yuxin Hou, Xiner Huang, Terrence Tsz-Tai Yuen, Yang Wang, Jinjin Zhang, Yao Xia, Lin-Lei Chen, Jian-Piao Cai, Anna Jinxia Zhang, Shuofeng Yuan, Jie Zhou, Bao-Zhong Zhang, Jian-Dong Huang, Kwok-Yung Yuen, Kelvin Kai-Wang To & Hin Chu. (2023) The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5. eBioMedicine 95, pages 104753.
Crossref
Bao‐Zhong Zhang, Yee‐Man Au‐Yeung, Terrence Tsz‐Tai Yuen, Xiaoyun Xu, Hua‐Rui Gong, Zheng Zeng, Renhao Li, Jinlian Hu, Hin Chu & Jian‐Dong Huang. (2023) Protein‐Based Face Mask with High SARS‐CoV‐2 Neutralization Ability and Breathability. Advanced Materials Technologies 8:18.
Crossref
Peng Zhang, Dongzi Liu, Lei Ji & Fenfen Dong. (2023) SARS-CoV-2 genomic characterization and evolution in China. Heliyon 9:8, pages e18980.
Crossref
Rafaela Milan Bonotto, Ana Mitrović, Izidor Sosič, Pamela Martínez-Orellana, Federica Dattola, Stanislav Gobec, Janko Kos & Alessandro Marcello. (2023) Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection. Antiviral Research 216, pages 105655.
Crossref
Jackson Emanuel, Jan Papies, Celine Galander, Julia M. Adler, Nicolas Heinemann, Kathrin Eschke, Sophie Merz, Hannah Pischon, Ruben Rose, Andi Krumbholz, Žarko Kulić, Martin D. Lehner, Jakob Trimpert & Marcel A. Müller. (2023) In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2. Frontiers in Pharmacology 14.
Crossref
Nina Reuter, Xiaohan Chen, Barbara Kropff, Antonia Sophia Peter, William J. Britt, Michael Mach, Klaus Überla & Marco Thomas. (2023) SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies. Viruses 15:7, pages 1500.
Crossref
Enya Qing & Tom Gallagher. (2023) Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages. mBio.
Crossref
Olivier Escaffre, Peter Szaniszlo, Gabor Törő, Caitlyn L. Vilas, Brenna J. Servantes, Ernesto Lopez, Terry L. Juelich, Corri B. Levine, Susan L. F. McLellan, Jessica C. Cardenas, Alexander N. Freiberg & Katalin Módis. (2023) Hydrogen Sulfide Ameliorates SARS-CoV-2-Associated Lung Endothelial Barrier Disruption. Biomedicines 11:7, pages 1790.
Crossref
Mercedes Soledad Nabaes Jodar, Carolina Torres, Laura Mojsiejczuk, Dolores Acuña, Laura Elena Valinotto, Stephanie Goya, Monica Natale, Silvina Lusso, Sofia Alexay, Ariel Amadio, Matias Irazoqui, Franco Fernandez, Maria Elina Acevedo, Cristina Alvarez Lopez, Andres Angelletti, Paula Aulicino, Elisa Bolatti, Bettina Brusés, Marco Cacciahue, Ana Cavatorta, Agustina Cerri, Andres Cordero, Humberto Debat, Maria Jose Dus Santos, Maria Florencia Eberhardt, Regina Ercole, Carlos Espul, Marisa Farber, Fabián Fay, Ailen Fernandez, Florencia Ferrini, Laura Formichelli, Santiago Ceballos, Fernando Gallego, Adriana Giri, Maria Gismondi, Raul Maximiliano Acevedo, Ivan Gramundi, María Eugenia Ibañez, Guido Konig, Viviana Leiva, Melina Lorenzini Campos, Horacio Lucero, Nathalie Marquez, Melina Mazzeo, Alicia Susana Mistchenko, Luciana Montoto, Marianne Muñoz, Victoria Nadalich, Cristina Nardi, Belén Ortiz, Luis Pianciola, Carolina Pintos, Andrea Puebla, Carolina Rastellini, Alejandro Ezequiel Rojas, Javier Sfalcin, Ariel Suarez, Clara Theaux, Guillermo Thomas, Estefania Tittarelli, Rosana Toro, Vanina Villanova, Gretel Wenk, Cecilia Ziehm, Maria Carla Zimmermann, Sebastian Zunino, Proyecto PAIS & Mariana Viegas. (2023) The Lambda Variant in Argentina: Analyzing the Evolution and Spread of SARS-CoV-2 Lineage C.37. Viruses 15:6, pages 1382.
Crossref
Yihua Li, Kun Wang, Hongmin Sun, Shuo Wu, Huiqiang Wang, Yuanyuan Shi, Xingxing Li, Haiyan Yan, Ge Yang, Mengyuan Wu, Yihong Li, Xiaotian Ding, Shuyi Si, Jiandong Jiang, Yu Du, Yuhuan Li & Bin Hong. (2023) Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2. Antiviral Research 214, pages 105606.
Crossref
Romano Strobelt, Karin Broennimann, Julia Adler & Yosef Shaul. (2023) SARS-CoV-2 Omicron Specific Mutations Affecting Infectivity, Fusogenicity, and Partial TMPRSS2-Independency. Viruses 15:5, pages 1129.
Crossref
Kaveh Sadeghi, Sevrin Zadheidar, Arghavan Zebardast, Ahmad Nejati, Marziyeh Faraji, Nastaran Ghavami, Shirin Kalantari, Vahid Salimi, Jila Yavarian, Adel Abedi, Nazanin Zahra Shafiei Jandaghi & Talat Mokhtari‐Azad. (2023) Genomic surveillance of SARS‐CoV‐2 strains circulating in Iran during six waves of the pandemic. Influenza and Other Respiratory Viruses 17:4.
Crossref
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, Camille Esneau, Mariana Ruiz Silva, Timothy Ison, Christina Fichter, Joseph A. Lopez, Deborah Chandra, Zin Naing, Joanna Caguicla, Daiyang Li, Gregory Walker, Supavadee Amatayakul-Chantler, Nathan Roth, Sandro Manni, Thomas Hauser, Thomas Barnes, Anna Condylios, Malinna Yeang, Maureen Wong, Charles S.P. Foster, Kenta Sato, Sharon Lee, Yang Song, Lijun Mao, Allison Sigmund, Amy Phu, Ann Marie Vande More, Stephanie Hunt, Mark Douglas, Ian Caterson, Warwick Britton, Kerrie Sandgren, Rowena Bull, Andrew Lloyd, Jamie Triccas, Stuart Tangye, Nathan W. Bartlett, David Darley, Gail Matthews, Damien J. Stark, Kathy Petoumenos, William D. Rawlinson, Ben Murrell, Fabienne Brilot, Anthony L. Cunningham, Anthony D. Kelleher, Anupriya Aggarwal & Stuart G. Turville. (2023) Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level. eBioMedicine 90, pages 104545.
Crossref
Yue Hu, Yuanmei Zhu, Yanying Yu, Nian Liu, Xiaohui Ju, Qiang Ding & Yuxian He. (2023) Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides. Antiviral Research 212, pages 105571.
Crossref
Chong Huang, Huiping Shuai, Jingxin Qiao, Yuxin Hou, Rui Zeng, Anjie Xia, Lingwan Xie, Zhen Fang, Yueyue Li, Chaemin Yoon, Qiao Huang, Bingjie Hu, Jing You, Baoxue Quan, Xiu Zhao, Nihong Guo, Shiyu Zhang, Ronggang Ma, Jiahao Zhang, Yifei Wang, Ruicheng Yang, Shanshan Zhang, Jinshan Nan, Haixing Xu, Falu Wang, Jian Lei, Hin Chu & Shengyong Yang. (2023) A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants. Signal Transduction and Targeted Therapy 8:1.
Crossref
Yanxia Chen, Wenchen Song, Can Li, Jiaxuan Wang, Feifei Liu, Zhanhong Ye, Peidi Ren, Yihan Tong, Junhua Li, Zhihua Ou, Andrew Chak-Yiu Lee, Jian-Piao Cai, Bosco Ho-Yin Wong, Jasper Fuk-Woo Chan, Kwok-Yung Yuen, Anna Jin-Xia Zhang & Hin Chu. (2023) COVID-19 mRNA vaccine protects against SARS-CoV-2 Omicron BA.1 infection in diet-induced obese mice through boosting host innate antiviral responses. eBioMedicine 89, pages 104485.
Crossref
Denisa Bojkova, Marco Bechtel, Tamara Rothenburger, Joshua D. Kandler, Lauren Hayes, Ruth Olmer, Ulrich Martin, Danny Jonigk, Sandra Ciesek, Mark N. Wass, Martin Michaelis & Jindrich Cinatljr.jr.. (2023) Omicron‐induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection. Journal of Medical Virology 95:3.
Crossref
Panke Qu, John P. Evans, Chaitanya Kurhade, Cong Zeng, Yi-Min Zheng, Kai Xu, Pei-Yong Shi, Xuping Xie & Shan-Lu Liu. (2023) Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants. mBio 14:1.
Crossref
Shi Yu, Huina Hu, Qiangyun Ai, Rong Bai, Kaixiong Ma, Minmin Zhou & Shaobo Wang. (2023) SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity. Viruses 15:3, pages 639.
Crossref
Luis Daniel González-Vázquez & Miguel Arenas. (2023) Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic. Genes 14:2, pages 407.
Crossref
Jasper Fuk-Woo Chan, Xiner Huang, Bingjie Hu, Yue ChaiHongyu Shi, Tianrenzheng ZhuTerrence Tsz-Tai YuenYuanchen LiuHuan LiuJialu ShiLei Wen, Huiping Shuai, Yuxin Hou, Chaemin Yoon, Jian-Piao Cai, Anna Jinxia ZhangJie Zhou, Feifei Yin, Shuofeng Yuan, Bao-Zhong ZhangMelinda A. Brindley, Zheng-Li Shi, Kwok-Yung Yuen & Hin Chu. (2023) Altered host protease determinants for SARS-CoV-2 Omicron. Science Advances 9:3.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.